0000000001247538

AUTHOR

Stefania Sferrazza

showing 6 related works from this author

Is Epstein-Barr virus infection associated with the pathogenesis of microscopic colitis?

2017

Abstract Background Epstein-Barr virus (EBV) has been associated with inflammation in the colon, particularly in patients with inflammatory bowel disease (IBD). Even if a relevant plasmocytosis, similar to IBD, is present in microscopic colitis (MC), the frequency of EBV infection in this setting is unknown. Objectives We aimed to compare the frequency of colonic EBV infection in patients with MC, ulcerative colitis (UC), and irritable bowel syndrome (IBS). Study design The frequency of colonic EBV infection in biopsies of 30 patients with MC, 30 patients with UC, and 30 controls with IBS was retrospectively assessed. PCR was performed to detect viral EBV DNA in colonic biopsies. In situ hy…

AdultMaleEpstein-Barr Virus InfectionsHerpesvirus 4 HumanColonBiopsymedicine.disease_causeInflammatory bowel diseasePolymerase Chain ReactionPathogenesisIrritable Bowel Syndrome03 medical and health sciences0302 clinical medicineMicroscopic colitishemic and lymphatic diseasesVirologyBiopsymedicineHumansEpstein–Barr virus infectionIrritable bowel syndromeIn Situ HybridizationAgedRetrospective Studiesmedicine.diagnostic_testbusiness.industryMiddle Agedmedicine.diseaseUlcerative colitisEpstein–Barr virusdigestive system diseasesColitis MicroscopicInfectious Diseases030220 oncology & carcinogenesisImmunologyDNA ViralRNA Viral030211 gastroenterology & hepatologyColitis UlcerativeFemalebusinessJournal of clinical virology : the official publication of the Pan American Society for Clinical Virology
researchProduct

Mevolonate Pathway:role of bisphosphonates and statins

2006

Cardiovascular diseases, i.e. high blood pressure, coronary heart disease, and stroke, and osteoporosis are public health problems, with several epidemiological links, and they might be related to each other in terms of pathogenesis and therapeutic agents. Bisphosphonates inhibit bone resorption and are used in the treatment of osteoporosis, whereas statins inhibit cholesterol biosynthesis and are used for the treatment of atherosclerosis and lipid metabolic disorders. Some late clinical studies suggested bisphosphonates may have beneficial effect in vivo on atherosclerotic progression, lipid profiles, and cardiovascular morbidity and mortality, whereas statins might increase bone density, …

Bisphosphonates statins atherosclerosis osteoporosis
researchProduct

Some cardiac effects during short-acting beta2-agonist theraphy in COPD subiects

2006

researchProduct

Bone turnover markers in postmenopausal womens treated with alendronate or risedronate: differences in early dynamics

2004

researchProduct

Il trattamento dell'iperparatiroidismo primitivo asintomatico:una controversia ancora aperta

2006

researchProduct

Il polimorfismo C4887A del gene CYP1A1 influenza il metabolismo estrogenico e la massa ossea

2004

polimorfismo C4887Agene CYP1A1Settore MED/09 - Medicina Internamassa ossea
researchProduct